Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
At screen 8 after seven goal and demographic screens but before a single clinical question is asked a modal slides over the flow and refuses to let the patient continue without an email address
S., Thim, L., Madsen, K
QS: Data curation, Methodology, Project administration, Writing original draft
Deprotection byproducts
Sourcing a tested material does not change the evidence picture described above: the approval and trial data belong to afamelanotide as a clinical product, they do not transfer to any research vial or to Melanotan 2, and nothing here is a therapeutic recommendation or a protocol for use
US$ 24.83
US$ 27.88
US$ 23.09
US$ 22.07
US$ 26.67
